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Abstract: 
 Obesity is a growing health problem in America affecting more than a third of 
Americans25 and is quickly becoming a global health crisis34. Recently there has been much 
interest in the possible link between the human gut microbiome and obesity as fecal transplants 
may serve as a potential therapeutic treatment. However, not much research has been done 
looking at a potential association with the human oral microbiome and obesity. In this thesis, I 
examined 976 individuals previously sequenced for their oral microbiome. Each sample was 
classified as underweight, normal, overweight, or obese, according to their BMI. I measured the 
microbial diversity of each sample and compared the relative diversity of each class through 
alpha and beta diversity. Alpha diversity measures the microbial diversity within an individual 
while beta diversity measures the microbial diversity between individuals.  I also investigated 
whether there was a clear association between monozygotic twins who were discordant in 
phenotype. While phyla-level changes were detected in the different weight class, overall the 
oral microbiome does not appear to be associated with human weight.   
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Introduction:  
 The human oral microbiome is composed of a diverse community of microorganisms 
which is comprised of a core set of bacterial genera that are commonly shared among 
individuals12,18,23. Bacteria accumulate in biofilms on various surfaces such as teeth and soft 
tissues like the gums5,6,23. The oral microbiome also exhibits long-term stability18 though this 
stability may be altered or influenced by a variety of factors including the environment of the 
host such as tooth loss as well as external factors like smoking and oral hygiene. Oral diseases, 
such as periodontitis and dental caries2,19,22,24, as well as other diseases such as diabetes14,24 and 
cancer 24have been associated with the oral microbiome. Currently there is much interest in the 
association between human weight and the gut microbiome, however, the role of the human oral 
microbiome and human weight is not well understood. 
 The association of the human gut microbiota and obesity has been the focus of intense 
investigation recently. Studies have characterized the composition and diversity of humans and 
mice exhibiting lean and obese phenotypes20,7. These studies have shown that obese individuals 
exhibit phyla-level changes in their gut microbiome as well as a decrease of microbial 
diversity7,13,21. Many papers have focused on the ratio of Firmicutes to Bacteroidetes in obese 
and lean individuals with obese individuals displaying higher levels of Firmicutes and lower 
levels of Bacteroidetes13,21,30,33,36. Other papers have contested these results7,35. Fecal transplant 
experiments in mice also demonstrate a link between the gut microbiome and obesity21.  
 The oral microbiome may serve as a biomarker for diseases related to the gut such as 
irritable bowel syndrome12,28 which suggests that the two microbiomes are correlated. Previous 
research has shown that both the human oral and gut microbiomes were correlated to biomarkers 
of atherosclerosis14 and the oral microbiome has been linked to irritable bowel syndrome26. The 
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mouth is also a “gateway” to the rest of the body. Bacteria that accumulate on the different 
intraoral tissues slough off into the saliva. The microorganisms in the saliva may also move 
along contiguous epithelial surfaces within the mouth and into the gut.   
 
Significance 
 Understanding the role of the microbiome in human health and disease is crucial for the 
development of disease diagnostics, therapeutics, and potentially personalized medicine24,32. The 
oral microbiome has been implicated in oral and systemic diseases as particularly severe forms 
of oral diseases may cause systemic diseases2,5,22,24. Periodontitis has been positively correlated 
with both diabetes and cardiovascular disease (CVD) suggesting that the oral microbiome may 
also be related to these systemic diseases5,14,24. Since obesity has been linked to diabetes and 
CVD the oral microbiome may also be associated with weight15,16. It has been previously 
suggested that oral bacteria may be related to the pathology of obesity8, however this finding has 
been contested in other papers3.  
 I investigated a possible correlation between the human oral microbiome and body mass 
index (BMI). I chose to use BMI because weight alone is not an adequate measurement of 
obesity since BMI also factors in an individual’s height.  This research holds the promise that if 
successful, the oral microbiome may prove a useful surrogate to studies of the gut microbiome 
that are more complicated to carry out. My plan was to investigate the microbial diversity in 
relation to four BMI phenotypes: underweight, normal, overweight, and obese. I intended to look 
at this correlation in all samples with height and weight data available, controlling for age and 
genetics. I also wanted to examine discordant twin pairs as well as twins whose phenotype 
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changed over two time points. I was able to analyze the first group as well as the discordant 
monozygotic twins, but I did not have time to investigate the other twin groups. 
 
Materials and Methods:  
Samples 
 Saliva samples were received from the Center of Antisocial Drug Dependence as well as 
the Colorado Twin Registry. DNA from samples was isolated in the laboratory as described 
previously42. 
Sequencing of Bacteria 
 The V4 region of the bacterial 16S small ribosomal subunit rDNA was sequenced via 
Illumina MiSeq as previously described4. The 16S rDNA region has constant and variable 
regions that can be sequenced to determine OTUs present in each sample.  Samples were 
prepared in triplicate and amplified via Polymerase Chain Reaction (PCR) with barcoded primers 
to amplify the 16S region of rDNA. Primers were designed as previously described1. The 
triplicates were pooled together after PCR to limit variation due to technique such as pipetting 
error and PCR machine variability. The samples were then run on a 2% e-gel for 20 minutes to 
verify that samples were amplified. PCR products were quantified using a picogreen assay 
according to manufacturer’s instructions. The PCR products from each barcoded subject were 
pooled in equimolar amounts (240ng/sample) by a graduate student, Brittany Demmitt, 
according to the Earth Microbiome1 protocol and then sent to the CU DNA Sequencing facility 
for sequencing on an Illumina MiSeq instrument. 
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Sample Selection 
 Data sets were assembled using RStudio (Version 0.99.441). The body mass index (BMI) 
was calculated according to a formula provided by the CDC as the weight in pounds divided by 
the height in inches multiplied by a constant ([(
𝐿𝑏𝑠
𝑖𝑛2
) × 703]).  and subjects were divided into 
obese, underweight, overweight or normal classes according to age-appropriate target BMI15.  
Samples collected only via a scope collection method were used (n=2110).  I took the complete 
set and removed any duplicate family members.  In other words, I only kept one member of each 
family in order to control for genetics.  For retention, I prioritized subjects who were classified, 
in order,  as obese, underweight, overweight, and normal.  This left me with 1020 subjects. 
Finally, each weight class was manipulated so that the mean age of each group was statistically 
similar to each other using a pair-wise t-test (n=976).  I considered controlling for sex, but 
there’s no evidence that sex influences the oral microbiome18.   
 While doing this initial investigation, I noticed that there were a large number of 
discordant twins. I identified 24 discordant monozygotic twin pairs, meaning they had identical 
genomes but differing phenotypes. I chose only pairs where one cotwin was obese and the other 
was normal weight. The discordant phenotypes in these twins suggests that a factor other than 
genetics may be driving their weight classes. The microbial diversity of these discordant twins 
were compared to the microbial diversity of 16 pairs of normal weight concordant monozygotic 
cotwins and 16 pairs of obese concordant cotwins.  There were considerably more normal 
concordant cotwins than obese cotwins, 16 pairs of normal concordant cotwins were randomly 
chosen out of the larger set. 
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Statistical Analyses 
 All statistical analyses were performed in QIIME29 (1.9.1) and RStudio37. The sequences 
from the Illumina MiSeq run were categorized into different operational taxonomic units (OTU) 
which is a categorization of the microbes based solely on their DNA sequence similarities. 
Brittany Demmitt created a table that contained the counts of the OTUs in all samples sequenced.  
I matched the sample IDs of the data sets described above to the OTU table in order to find the 
frequency of OTUs of each individual. The filtered OTU table was then rarefied to a depth of 
2500 reads/sample. OTUs were then filtered for abundance. The OTUs were filtered to those 
present in 50% of the respective samples and were present a minimum of 5 times. Alpha 
diversity, which measures the microbial diversity within an individual, was performed using a 
PD whole tree metric. This metric is based on a phylogenetic tree and uses branch length to 
determine diversity39. Beta diversity analysis, a measure of microbial diversity between 
individuals,  using the Bray-Curtis metrics were used on all data sets. Bray-Curtis quantifies the 
compositional diversity between individuals based on OTU counts40. Results were plotted on a 
principal component plot via emperor38. A linear regression analysis was performed on the total 
sample set (n=976) of the principal components, independent variable, and the weight classes as 
well as the raw BMI scores, dependent variable. Other covariates (age, sex, MiSeq run, and 
sample collection year) were all controlled for in all regression analyses. An alpha diversity 
analysis was performed for both data sets as well, and a comparison of the frequency of different 
phyla-level OTUs was performed on each data set.  
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Results 
Correlation between weight and the oral microbiome in unrelated individuals  
 I looked at the alpha diversity of the different weight classes using the PD whole tree 
metric. Unlike the results seen in the gut microbiome between lean and obese individuals the 
alpha diversity between all phenotypes was similar (Figure 1). This suggests the microbial 
diversity between all the weight classes is the same, and there are no significant differences in 
the oral microbiome between any of the four phenotypes.  
 
Figure 1: Alpha diversity of all samples  
Alpha diversity curve showing the four different weight classes. Alpha diversity was measured using 
PD_whole_tree metrics. Red is normal, blue is obese, orange is overweight and green is underweight.  
 
 I next performed a beta diversity analysis using the non-tree based Bray-Curtis metrics on 
all the unrelated individuals (n=976). Figure 2 represents a 2D plot of the beta diversity analysis 
of the first three principal components. No clear clustering of the different weight classes was 
observed from beta diversity, suggesting that the oral microbiome is not sufficiently distinct 
between obese and lean individuals. However, I noticed that many of the obese samples were 
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near principal coordinate 1 (PC1) which explains about 20% of the variation in the sample and 
principal coordinate 2 (PC2) which explains about 8% of the variation in the sample. I then 
performed a multivariate linear regression against PC1 and PC2 to see if either of these 
components were significantly related to the obese phenotype. 
 
Figure 2: Beta diversity of all unrelated individuals 
2D plots of the first three principal components of Bray-Curtis beta diversity analysis. Each point represents an 
individual and is plotted in a distance matrix relatively to the diversity of each other. Points are colored by their 
respective weight class. Red is normal, blue is obese, orange is overweight, and green is underweight.  
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Linear regression of PC1 and PC2  
 I performed a linear regression of multiple possible covariates against PC1, PC2 and PC3. 
I regressed out the weight classifications using normal weight as the reference phenotype against 
other variables (sex, age, MiSeq run, and sample collection year). I also performed a regression 
of the principal coordinates for the raw BMI numbers, regressing out the same covariates as 
above. For PC1 the beta coefficient of the obese weight class is -0.056 (Table 1) which was 
significant (P<0.001). On average individuals of the obese phenotype were 0.056 units below 
individual’s of normal phenotype along PC1. When only the raw BMI scores were used I 
retained significance (P<0.001). This suggests that the distribution of heavier individuals along 
PC1 which explains about 20% of the variation of the population was significantly different 
compared to normal weight individuals.  
 When weight classes were regressed against PC2, the estimate for obese compared to 
normal was -0.028 (Table 1) which was also significant (P<0.01). However, when the raw BMI 
numbers were regressed against PC2 significance was lost (P>0.1), suggesting that overall 
weight did not significantly contribute to plotting along PC2. Both phenotype and BMI scores 
were regressed against PC3, but no significance was found (Table 1).  
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PC1 (ß) Coefficient  P value   
Obese -0.0560 0.0013**   
Overweight -0.0200 0.1716 R2=0.0816 
Underweight 0.0020 0.9137   
BMI -0.0040 0.0011** R2=0.0829 
PC2 (ß) Coefficient P value   
Obese -0.0284 0.0148*   
Overweight -0.0051 0.6052 R2=0.0218 
Underweight -0.0039 0.7869   
BMI -0.0012 0.1291 R2=0.0201 
PC3 (ß) Coefficient P value   
Obese 0.0007 0.4510   
Overweight -0.0039 0.9420 R2=0.0189 
Underweight 0.0037 0.6260   
BMI 0.0236 0.3680 R2=0.0213 
Table 1: Linear regression analysis of principal components 1 to 3.  
Weight classifications and raw BMI scores were regressed against principal components 1 through 3. Multiple 
covariates were regressed out as well. Weight classes were all baseline to the normal phenotype. ß coefficients are 
the average distance of the class as compared to the normal phenotype. *P<0.05, **P<0.01, ***P<-0.001. 
 
Frequency of phyla-level OTUs  
 I next investigated whether there were any phyla-level changes of OTUs in the different 
weight classes of unrelated individuals. The fractional means were obtained via a Kruskal-Wallis 
nonparametric test41. While in the gut, the relative abundance of Firmicutes and Bacteroidetes 
have often been shown to have a correlation with human weight, in the oral microbiome 
Actinobacteria appeared to be significantly less abundant in obese individuals compared to the 
other weight classes (Table 2). To ensure that the difference between underweight and obese 
individuals was not driving this significance, I next compared only normal and obese individuals 
(Table 3). Again, I found that Actinobacteria was significantly less abundant in obese individuals 
compared to normal individuals (P <0.001). The relative abundance of Actinobacteria maintains 
its significance even with the Bonferroni and FDR corrected p values (Table 2 and 3). 
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Phyla 
Test-
Statistic P FDR_P Bonferroni_P obese normal overweight underweight 
Actinobacteria 16.67 0.0008*** 0.0041** 0.0041** 0.10 0.12 0.12 0.13 
Proteobacteria 5.94 0.1148 0.287 0.574 0.14 0.13 0.12 0.13 
Fusobacteria 2.8 0.4232 0.7053 1.000 0.06 0.06 0.06 0.06 
Bacteroidetes 0.87 0.8318 0.9301 1.000 0.13 0.13 0.13 0.13 
Firmicutes 0.45 0.9301 0.9301 1.000 0.56 0.56 0.56 0.55 
 
Table 2: Relative abundance of different phyla in different weight classes  
Table lists five core phyla of the human oral microbiome and their mean fractional abundance in each weight class. 
Analysis performed on all unrelated individuals (n=976) A Kruskal-Wallis analysis was done to calculate the p 
value. *P<0.5, **P<0.01, ***P<0.001 
 
 
Table 3: Relative abundance of phyla in normal and obese individuals 
Table lists five core phyla of the human oral microbiome and mean fractional abundance. Only individuals classified 
as obese or normal were used (n=702). P value calculated from Kruskal-Wallis analysis. *P<0.5, **P<0.01, 
***P<0.001 
 
Microbial diversity of discordant monozygotic twins   
 Next I investigated whether the oral microbiome was associated with discordant weight 
phenotypes in monozygotic twins. If the oral microbiome plays a role in the discordant 
phenotypes, I would expect to see the discordant cotwins plotted more distantly from each other 
on a principal coordinate plot, and the concordant cotwins to be closer. I performed a beta 
diversity measure on normal weight and obese discordant twins (Figure 3A) in order to visualize 
the microbial diversity between twin pairs. The discordant twins generally were plotted with 
observable distance between them, however I did not have the time to do the work necessary to 
quantify the vectors. They were then compared to concordant normal and concordant obese twin 
pairs (Figure 3B-C). Visually, the concordant twins also appear far apart on the principal 
component plot indicating that the oral microbiome does not appear to associate with the weight 
Phyla Test-Statistic P FDR_P Bonferroni_P obese normal 
Actinobacteria 15.65 7.62E-05*** 0.0004 0.0004 0.10 0.12 
Proteobacteria 4.58 0.0323* 0.0808 0.1615 0.14 0.13 
Fusobacteria 2.12 0.1450 0.2417 0.7251 0.06 0.06 
Bacteroidetes 0.64 0.4230 0.5288 1.0000 0.13 0.13 
Firmicutes 0.05 0.8306 0.8306 1.0000 0.56 0.56 
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classes in monozygotic twins. Again, due to time the vectors were not quantified, so it is hard to 
determine if the discordant twin pairs were significantly more distal to each other than the 
concordant twin pairs.  
 
Figure 3: Beta diversity PCoA of discordant and concordant twin pairs 
Beta diversity was performed using non phylogenetic tree based Bray-Curtis metric. Vectors connect twin pairs to 
each other. (A) Discordant twin pairs. Blue indicates obese weight class, red indicates normal weight class. (B) 
Concordant normal weight class twin pairs. (C) Concordant obese weight class twin pairs.  
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Discussion  
 Although there has been plenty of evidence correlating the gut microbiome to human 
weight and obesity, the oral microbiome does not appear to have an association with human 
weight as has been previously discussed3. Although some oral diseases have been linked to 
systemic diseases that are related to obesity, I did not see a clear correlation of oral microbial 
diversity and BMI. This may be due to the fact that I did not have information on the oral health 
of these individuals, and they were not collected for oral diseases. Drug usage may have also 
affected the results as many drugs such as tobacco and alcohol may affect the oral microbiome.  
 I did find significance in the distribution of the obese weight class and BMI raw numbers 
along PC1, indicating that the obese phenotype in this population is clustering around this 
principal component that explains most of the variation in the population as a whole. However, 
looking at the beta and alpha diversity, the association between the oral microbiome and body 
weight ultimately appears unrelated in this population.  
 Similar to the gut microbiome, phyla-level changes were observed in the different weight 
classes. It has been previously proposed that higher levels of Actinobacteria20 in the gut 
microbiome is associated with obesity. However, in the oral microbiome, obesity was related to a 
decrease in the total fractional mean of Actinobacteria compared to all other phenotypes and the 
normal phenotype. Actinobacteria is one of the core phylum of the oral microbiome, but whether 
one species of bacteria from this phyla may act as a marker remains unknown. It has also been 
previously found that the presence of Selenomonas noxia in the oral microbiome was linked to 
overweight women8. The selenomonas genus was not present in this data set, so I could not look 
at it as a biomarker.  
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 The results of the monozygotic twins remain unclear though the oral microbiome does 
not appear to be related to the discordant phenotype in twin pairs. Qualitatively, the beta 
diversity of the coordinate and discordant twin pairs appear similar. However, quantitatively it is 
unknown whether any differences are observed between the different twin groups.  
 While I believe my results do not show a clear correlation between the human oral 
microbiome and BMI, the correlation between the obese phenotype and PC1 as well as the 
phyla-level changes detected in the obese weight class are promising. A larger and better-defined 
sample would clarify this. Considering the possible link between periodontitis and other systemic 
diseases correlated to obesity, this sample population may not have revealed a clear correlation 
due to the lack of medical information available. These samples were not collected for 
periodontitis or other diseases that have a link to obesity. Further studies that control for the 
potential link between oral diseases and other systemic diseases may reveal an association with 
the oral microbiome and human weight.  
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Appendix I 
Verifying imputations   
 Along with this thesis project, I verified single nucleotide polymorphism (SNP) 
genotypes via sanger sequencing from imputations. An imputation is a prediction of a 
individual’s SNP genotype based on haplotype blocks. Each sample received a dosage score 
which expressed confidence for the imputation. I verified these imputation predictions by 
sequencing individual’s to assess their genotype for the SNP. I sequenced two SNPs, rs7444887 
(n=53) and rs77693952 (n=13). Primers were designed through Primer Design and Tools 
provided by BiSearch (Figure 1A-B) and oligos were ordered from IDT Inc. Primers were 
optimized for polymerase chain reaction (PCR) before samples were run on the optimized PCR 
program and then run on a 1% agarose gel to ensure that all samples were amplified.  
 To prepare the samples for sequencing, they were purified via the QIAquick PCR 
purification kit according to manufacturer’s instructions (Qiagen). Purified samples were 
quantified for DNA concentration [ng/µl] on a Nanodrop2000 spectrometer. Samples were then 
diluted and prepared for sequencing by ACGT Inc. according to their low-cost option (LCO) 
single-pass DNA sequencing standards. Samples were diluted down to 3ng in 5 µl and the 
forward and reverse primers were custom mixed in at a concentration of 10pmol/µl. Prepared 
samples were then sent for sequencing at ACGT Inc. Examples of the results can be seen in 
Figure 1C-D. Of the 53 samples for rs7444887 all controls validated, and only 3 individuals with 
low dosage scores (<0.5) did not validate. For rs77693952 all controls validated, but 1 individual 
with a high dosage score (>0.99) did not validate.  
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Figure 1: Primers and sequencing results for imputation samples 
(A) The forward and reverse primers designed for rs7444887. (B) The forward and reverse primers designed for 
rs77693952. (C) Example sequencing results for two different samples using rs7444887 primers. Reference allele is 
A/T. Highlighted peak is the SNP. Top picture shows a homozygous genotype call while bottom picture shows a 
heterozygous genotype call. (D) Example sequencing results for two different samples using rs77693952 primers. 
Reference allele is G/C. Highlighted peak is the SNP. Top picture shows a homozygous genotype call while bottom 
picture shows a heterozygous genotype call. 
 
